Logitech (LOGI):
 A press release came out at 10 p.m. last night. According to the release, the computer peripheral maker said

"it has withdrawn its fiscal year 2009 growth targets for sales and operating income due to the deepening global recession. The Company did not provide revised targets and plans to update investors on business conditions and performance during its briefing on third-quarter results on Jan. 20, 2009.”

Folks, I don’t think I have to tell you that this isn't good news. However, I took a gander at the insider data, and it appears there were a couple of purchases over the last several months.

I’m not sure what that signals, but if nothing else, maybe the purchases will give those insiders some motivation to find ways to get the stock moving.

Amedisys (AMED):
 The Louisiana-based home-nursing company offered up some guidance for 2009. According to the release: “Diluted earnings per share in 2009 is expected to be in the range of $4.10 to $4.30 based on an estimated 27.5 million shares outstanding, also excluding the effects of future acquisitions, if they are made.”

At first blush, this looks like a nice surprise. The company is expected to earn $3.82. In short, I think the stock rocks today. The only negative I see in this -- I frequently find myself playing devil’s advocate -- is that the company has set the bar a little high. I think they better hit that estimate or run the risk of seeing their share price get pummeled.

Apple (AAPL):
 I guess Jobs’ comments about his health didn’t satisfy some in the investment community. I was watching CNBC last night and this morning, and many are saying that his comments only raise further questions.

I’m not a doctor, but what more do these people want? Should the company have a line item on its income statement that reads "Jobs' blood test," and have a small blood sample sent to each shareholder for analysis? I just think this story is getting too much play - leave the guy alone, already.

Just my 2 cents.

Have a great day!